Filing Details

Accession Number:
0001085146-17-000621
Form Type:
13G Filing
Publication Date:
2017-02-13 17:12:39
Filed By:
Consonance Capital Management
Company:
Ani Pharmaceuticals Inc (NASDAQ:ANIP)
Filing Date:
2017-02-13
SEC Url:
13G Filing
Ownership Summary

Please notice the below summary table is generated without human intervention and may contain errors. Please refer to the complete filing displayed below for exact figures.

Name Sole Voting Power Shared Voting Power Sole Dispositive Power Shared Dispositive Power Aggregate Amount Owned Power Percent of Class
Consonance Capital Opportunity Fund Management 6 11,186 8 11,186 11,186 0.1%
Consonance Capman GP 6 491,608 8 491,608 491,608 4.25%
Filing
UNITED STATES
SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549
SCHEDULE 13G
Under the Securities Exchange Act of 1934
(Amendment No. 2)*
ANI Pharmaceuticals, Inc.
(Name of Issuer)
Common Stock, par value $0.0001 per share
(Title of Class of Securities)
00182C103
(CUSIP Number)
December 31, 2016
(Date of Event which Requires Filing of this Statement)
Check the appropriate box to designate the rule pursuant to which this Schedule is filed:
[X] Rule 13d-1(b)
[   ] Rule 13d-1(c)
[   ] Rule 13d-1(d)
* The remainder of this cover page shall be filled out for a reporting person's initial filing on this form with respect to the subject class of securities, and for any subsequent amendment containing information which would alter the disclosures provided in a prior cover page.
The information required in the remainder of this cover page shall not be deemed to be "filed" for the purpose of Section 18 of the Securities Exchange Act of 1934 ("Act") or otherwise subject to the liabilities of that section of the Act but shall be subject to all other provisions of the Act (however, see Instructions).
CUSIP No.: 00182C103
       
1
NAME OF REPORTING PERSON
Consonance Capital Opportunity Fund Management LP
I.R.S. IDENTIFICATION NO. OF ABOVE PERSON (ENTITIES ONLY)
2
CHECK THE APPROPRIATE BOX IF A MEMBER OF A GROUP
(a) [   ]
(b) [   ]
3 SEC USE ONLY
4
CITIZENSHIP OR PLACE OF ORGANIZATION
Delaware USA
NUMBER OF SHARES BENEFICIALLY OWNED BY EACH REPORTING PERSON WITH 5
SOLE VOTING POWER
6
SHARED VOTING POWER
11,186
7
SOLE DISPOSITIVE POWER
8
SHARED DISPOSITIVE POWER
11,186
9
AGGREGATE AMOUNT BENEFICIALLY OWNED BY EACH REPORTING PERSON
11,186
10
CHECK BOX IF THE AGGREGATE AMOUNT IN ROW (9) EXCLUDES CERTAIN SHARES
[   ]
11
PERCENT OF CLASS REPRESENTED BY AMOUNT IN ROW (9)
0.1% Based on 11,580,392 shares of common stock outstanding as of October 27, 2016 as reported in the Issuers Form 10-Q filed with the SEC on October 27, 2016
12
TYPE OF REPORTING PERSON
IA, PN
CUSIP No.: 00182C103
       
1
NAME OF REPORTING PERSON
Consonance Capman GP LLC
I.R.S. IDENTIFICATION NO. OF ABOVE PERSON (ENTITIES ONLY)
2
CHECK THE APPROPRIATE BOX IF A MEMBER OF A GROUP
(a) [   ]
(b) [   ]
3 SEC USE ONLY
4
CITIZENSHIP OR PLACE OF ORGANIZATION
Delaware USA
NUMBER OF SHARES BENEFICIALLY OWNED BY EACH REPORTING PERSON WITH 5
SOLE VOTING POWER
6
SHARED VOTING POWER
491,608
7
SOLE DISPOSITIVE POWER
8
SHARED DISPOSITIVE POWER
491,608
9
AGGREGATE AMOUNT BENEFICIALLY OWNED BY EACH REPORTING PERSON
491,608
10
CHECK BOX IF THE AGGREGATE AMOUNT IN ROW (9) EXCLUDES CERTAIN SHARES
[   ]
11
PERCENT OF CLASS REPRESENTED BY AMOUNT IN ROW (9)
4.25% Based on 11,580,392 shares of common stock outstanding as of October 27, 2016 as reported in the Issuers Form 10-Q filed with the SEC on October 27, 2016
12
TYPE OF REPORTING PERSON
HC, OO
CUSIP No.: 00182C103
SIGNATURE
After reasonable inquiry and to the best of my knowledge and belief, I certify that the information set forth in this statement is true, complete and correct.
February 10 2017
CONSONANCE CAPITAL OPPORTUNITY FUND MANAGEMENT LP
By:
Consonance Capman GP LLC /s/ Mitchell Blutt
Name:
Mitchell Blutt
Title:
Manager & Member